|
1
|
Yoshioka Y, Toratani S, Ogawa I and
Okamaoto T: Ameloblastic carcinoma, secondary type, of the
mandible: a case report. J Oral Maxillofac Surg. 71:e58–e62.
2013.
|
|
2
|
Barnes L, Eveson J, Reichat P and
Sidransky D: World Health Organization Classification of Tumours.
Pathology and Genetics of Head and Neck Tumours. IARC Press; Lyon,
France: pp. 286–291. 2005
|
|
3
|
Karakida K, Aoki T, Sakamoto H, et al:
Ameloblastic carcinoma, secondary type: a case report. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 110:e33–e37. 2010.
|
|
4
|
França DC, Moreira JM Jr, De Aguiar SM, De
Carvalhos AA and Goiato MC: Ameloblastic carcinoma of the maxilla:
A case report. Oncol Lett. 4:1297–1300. 2012.
|
|
5
|
Madan M, Singh J, Arora R and Bansal M:
Ameloblastic carcinoma: A case report and literature review. Int J
Appl Basic Med Res. 1:54–56. 2011.
|
|
6
|
Glaudemans AW, Enting RH, Heesters MA, et
al: Value of 11C-methionine PET in imaging brain tumours and
metastases. Eur J Nucl Med Mol Imaging. 40:615–635. 2013.
|
|
7
|
Crippa F, Alessi A and Serafini GL: PET
with radiolabeled aminoacid. Q J Nucl Med Mol Imaging. 56:151–162.
2012.
|
|
8
|
Gulyás B and Halldin C: New PET
radiopharmaceuticals beyond FDG for brain tumor imaging. Q J Nucl
Med Mol Imaging. 56:173–190. 2012.
|
|
9
|
Temporale H, Zatoński T, Roszkowska A and
Kręcicki T: Ameloblastoma of the nasal septum origin: a case
report. Case Rep Otolaryngol. Sep 21–2013.(Epub ahead of
print).
|
|
10
|
Takeuchi S, Kobayashi K, Minakawa T, Azumi
T and Fukushima M: Metastatic ameloblastoma of the skull. Surg
Neurol. 15:182–185. 1981.
|
|
11
|
Azumi T, Nakajima T, Takeuchi S, Fukushima
M and Ishiki T: Malignant ameloblastoma with metastasis to the
skull: report of case. J Oral Surg. 39:690–696. 1981.
|
|
12
|
Sato K, Sudo S, Fukuya Y and Sakuma H:
Maxillary ameloblastoma with intracranial invasion - case report.
Neurol Med Chir (Tokyo). 34:704–707. 1994.
|
|
13
|
Hayashi N, Iwata J, Masaoka N, Ueno H,
Ohtsuki Y and Moriki T: Ameloblastoma of the mandible metastasizing
to the orbit with malignant transformation. A histopathological and
immunohistochemical study. Virchows Arch. 430:501–507. 1997.
|
|
14
|
Leibovitch I, Schwarcz RM, Modjtahedi S,
Selva D and Goldberg RA: Orbital invasion by recurrent maxillary
ameloblastoma. Ophthalmology. 113:1227–1230. 2006.
|
|
15
|
Benlyazid A, Lacroix-Triki M, Aziza R,
Gomez-Brouchet A, Guichard M and Sarini J: Ameloblastic carcinoma
of the maxilla: case report and review of the literature. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 104:e17–e24. 2007.
|
|
16
|
Ozlugedik S, Ozcan M, Basturk O, et al:
Ameloblastic carcinoma arising from anterior skull base. Skull
Base. 15:269–273. 2005.
|
|
17
|
Devenney-Cakir B, Dunfee B, Subramaniam R,
et al: Ameloblastic carcinoma of the mandible with metastasis to
the skull and lung: advanced imaging appearance including computed
tomography, magnetic resonance imaging and positron emission
tomography computed tomography. Dentomaxillofacial Radiol.
39:449–453. 2010.
|
|
18
|
Matsuzaki H, Katase N, Hara M, et al:
Ameloblastic carcinoma: a case report with radiological features of
computed tomography and magnetic resonance imaging and positron
emission tomography. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 112:e40–e47. 2011.
|
|
19
|
Davis KR, New PF, Solis OJ and Roberson
GH: A review of the findings on computed cranial tomography
following intravenous contrast media. Rev Interam Radiol. 2:15–18.
1977.
|
|
20
|
Graif M and Steiner RE: Contrast-enhanced
magnetic resonance imaging of tumours of the central nervous
system: a clinical review. Br J Radiol. 59:865–873. 1986.
|
|
21
|
Wilms G, Marchal G, Demaerel PH, Van Hecke
P and Baert AL: Gadolinium-enhanced MRI of intracranial lesions. A
review of indications and results. Clin Imaging. 15:153–165.
1991.
|
|
22
|
Dillon WP: Imaging of central nervous
system tumors. Curr Opin Radiol. 3:46–50. 1991.
|
|
23
|
Olivero WC, Dulebohn SC and Lister JR: The
use of PET in evaluating patients with primary brain tumours: is it
useful? J Neurol Neurosurg Psychiatry. 58:250–252. 1995.
|
|
24
|
Chen W: Clinical applications of PET in
brain tumors. J Nucl Med. 48:1468–1481. 2007.
|
|
25
|
Van Laere K, Ceyssens S, Van Calenbergh F,
et al: Direct comparison of 18F-FDG and
11C-methionine PET in suspected recurrence of glioma:
sensitivity, inter-observer variability and prognostic value. Eur J
Nucl Med Mol Imaging. 32:39–51. 2005.
|
|
26
|
Koizumi M, Saga T, Yoshikawa K, et al:
11C-methionine-PET for evaluation of carbon ion
radiotherapy in patients with pelvic recurrence of rectal cancer.
Mol Imaging Biol. 10:374–380. 2008.
|
